The trademark application IMUQUIN was filed by Nutramax Laboratories, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 26, 2022, and it was registered by office on August 3, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on November 16, 2023.